A Look at Lazard’s Valuation Following the Appointment of Tech Executive Dmitry Shevelenko to Its Board
Lazard (NYSE:LAZ) just shook things up by appointing Dmitry Shevelenko, Chief Business Officer of Perplexity, to its Board of Directors. Shevelenko’s background, spanning leadership stints at Uber, LinkedIn, and Meta, points to a boardroom that is getting serious about technology and operational innovation. While executive appointments do not always move the needle overnight, this one hints at intentions beyond tradition, namely, adapting fast to the tech-driven shifts reshaping global finance.
This addition to Lazard’s board comes at a time when the company’s stock has seen a steady climb this year, up 11% on a year-to-date basis and an impressive 25% over the past twelve months. Momentum really picked up in the past 3 months, with shares rising nearly 32%. Meanwhile, annual revenue and net income have both shown healthy growth, which may be encouraging investors to reconsider how Lazard is valued compared to peers.
With new tech expertise now at the table and shares on the move, does Lazard still have room to run, or has the market already accounted for its innovation pivot?
Most Popular Narrative: 3.5% Undervalued
According to the most widely followed narrative, Lazard appears to be trading modestly below its estimated fair value. Analysts believe the company’s recent expansion efforts, improving margins, and robust forecasted growth justify a higher price than the current market level.
“Efforts to broaden financial advisory services with additions in healthcare, financial sponsors, and restructuring suggest increased investment in personnel, which might lead to temporary elevated expenses without corresponding revenue growth. Continued geopolitical advisory expansion and recruitment may increase operating costs faster than revenue from these services materializes, adversely affecting net margins in the short term.”
Curious about the engine behind Lazard’s valuation story? One big bet: the company’s future profit margin and earnings growth are set to sprint ahead of today’s levels, driving up projected value. Want the playbook behind this ‘undervalued’ rating? The real surprise is how ambitious these financial estimates are, as well as the shift required to make them reality.
Result: Fair Value of $58.20 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.However, continued diversification and expansion in Lazard’s advisory business or asset management flows could help offset short-term cost pressures and support future growth.
Find out about the key risks to this Lazard narrative.Another View: DCF Model Weighs In
While analyst targets suggest only modest upside, our DCF model offers a second opinion. It points to Lazard being even further below its fair value and challenges whether the market is fully pricing in the future. Which lens tells the truer story?
Look into how the SWS DCF model arrives at its fair value.Build Your Own Lazard Narrative
If you think the numbers tell a different story, or want to dig into the details yourself, you can craft your own Lazard narrative in under three minutes. Do it your way
A great starting point for your Lazard research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
Looking for More Investment Ideas?
Why limit your opportunities to just one stock? Set yourself up for smarter decisions by tapping into new trends and bold prospects that others might miss.
- Spot hidden gems primed for potential with undervalued stocks based on cash flows before they catch everyone else's attention.
- Tap into unstoppable innovation by seeking out AI penny stocks at the forefront of artificial intelligence breakthroughs.
- Lock in steady returns by checking out dividend stocks with yields > 3% aiming for yields above 3% to reinforce your financial foundation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Lazard might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com